Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978793 · ClinicalTrials.gov registry record
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 31
- Enrollment target
NCT03978793: Completed study, sponsored by Ohio State University.
NCT03978793 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03978793 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.
Primary Outcome
Measurement of dried blood spots for TDF/FTC concentrations
Interventions
- DEVICE MyTPill, a digital pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2025-04-30 |
What the finished NCT03978793 record still lists
NCT03978793 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MyTPill, a digital pill is the first listed.
NCT03978793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03978793 about?
NCT03978793 is a clinical study titled "MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users". This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.
What is the current status of trial NCT03978793?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2021-02-01. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT03978793?
The interventions under investigation include: MyTPill, a digital pill (DEVICE).
Who is sponsoring clinical trial NCT03978793?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI